Research groups
Colleges
Bethan O'Connor
Postdoctoral Research Scientist
My work as a postdoctoral researcher in the Cragg group focuses on investigating the impact that dopamine transporters have on dopamine axon activation and dopamine release in the striatum, and how the function of these transporters might converge with that of γ-aminobutyric acid (GABA) receptors. To do this, I use a combination of approaches in ex vivo brain slices, such as fast-scan cyclic voltammetry to measure dopamine release, and genetically-encoded fluorescent sensors for measuring changes in axonal membrane potential. This work is a continuation of research done during my PhD in the Cragg group, which I completed in 2025.
Prior to joining the Cragg group, I was a research assistant in Dr. Rodrigo España’s group at Drexel University, where I was involved in a range of projects relating to how changes in dopamine signalling modulate cocaine self-administration behaviour. Before this, I completed by BSc (Hons) in Psychology with Cognitive Neuroscience at the University of Leicester. There, I undertook research in Dr. Andrew Young’s group, investigating how the regulation of striatal dopamine by muscarinic acetylcholine receptors might be altered in the sub-chronic phencyclidine model of schizophrenia.
Recent publications
-
Gabapentinoids promote striatal dopamine release and rescue multiple deficits of a mouse model of early Parkinson’s
Preprint
Brimblecombe KR. et al, (2025)
-
Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Journal article
Brimblecombe KR. et al, (2024), Eur J Neurosci, 59, 1242 - 1259
-
Voltage sensor imaging in a population of dopaminergic axons in the mouse striatum v1
Preprint
Duquenoy L. et al, (2024)
-
Incubation of cocaine craving coincides with changes in dopamine terminal neurotransmission.
Journal article
Alonso IP. et al, (2022), Addict Neurosci, 3
-
Individual differences in dopamine uptake in the dorsomedial striatum prior to cocaine exposure predict motivation for cocaine in male rats.
Journal article
Shaw JK. et al, (2021), Neuropsychopharmacology, 46, 1757 - 1767
-
Screening for drugs to reduce zebrafish aggression identifies caffeine and sildenafil.
Journal article
Gutiérrez HC. et al, (2020), Eur Neuropsychopharmacol, 30, 17 - 29

